Back to User profile » Professor Shahjada Selim
Papers published by Professor Shahjada Selim:
Real-World Effectiveness and Safety of Imeglimin in Type 2 Diabetes: Prospective Multi-Center Study in Bangladesh
Selim S, Rahman MH, Mustari M, Mohiuddin SM, Ahammed A, Hannan MA, Sharifuzzaman M, Mahjabeen S, Saifuddin M, Rahman MM, Afsana F, Raunak AIB
Diabetes, Metabolic Syndrome and Obesity 2026, 19:576436
Published Date: 3 February 2026
Exploring the Real-World Effectiveness of Empagliflozin and Linagliptin Fixed-Dose Combination in Type 2 Diabetes Patients of Bangladesh: A Prospective Multi-Center Observational Study
Sharifuzzaman M, Paul AK, Akteruzzaman M, Bhuiyan SH, Haider R, Sharker S, Sultana D, Alam KM, Abu Zafar S, Kashem MA, Abu Zahid M, Islam AN, Abedin MZ, Anar F, Hasan MF, Selim S, Islam S, Ahammed A, Hosen M, Qureshi NK, Hossain MA, Begum A, Afrooz F, Kobir AM, Akter F, Mustafa SJ, Rahman MM, Saifuddin M
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4465-4482
Published Date: 4 December 2025
Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh
Pathan MF, Akter N, Selim S, Saifuddin M, Qureshi NK, Kamrul-Hasan ABM, Hannan MA, Ahmed MAU, Mustari M, Chakraborty AK
Diabetes, Metabolic Syndrome and Obesity 2022, 15:4011-4021
Published Date: 22 December 2022
Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19
Pathan F, Selim S, Fariduddin M, Rahman MH, Ashrafuzzaman SM, Afsana F, Qureshi NK, Hossain T, Saifuddin M, Kamrul-Hasan AB, Mir AS
Diabetes, Metabolic Syndrome and Obesity 2021, 14:2217-2228
Published Date: 18 May 2021